glp-1 and parkinson's disease Schematic representation of the repurposing journey of the Glucagon-like peptide-1 receptor agonists in

Name: glp-1 and parkinson's disease Schematic representation of the repurposing journey of the Glucagon-like peptide-1 receptor agonists in
Brand: paygroup.it
SKU: 10328836927
Price: 21.52 USD
Availability: InStock
Rating: 4.0774 (24 reviews)

SKU: 10328836927

4.1

EUR21.52 EUR42.52

Pay in 4 interest-free payments of $5.38 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Aug 1 - Aug 6

Live Spec

Glucagon like peptide 1 receptor agonists in movement disorders: From Parkinson's disease to the broader spectrum Mechanisms, evidence, and future directions ScienceDirect A new Science Perspective highlights the growing body of evidence that hints at the potential of GLP 1based medications in treating conditions other than diabetes and obesity, including cardiovascular disease and neurodegenerative disorders. Glucagon like peptide 1 medicines in neurological and psychiatric disorders: Cell Reports Medicine Frontiers Molecular mechanisms underlying Parkinson's disease and role of phytochemicals, synuclein, sirtuins, and incretin mimetics in potential therapy GLP 1 for Weight Loss and Diabetes Open Medscience

Store: paygroup.it · Domain: paygroup.it

Description

cruzi and other trypanosomes (De Jesus et al., 2016